Related Experiment Video
Updated: May 29, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning
Luis Mariano Esteban1,2, Ángel Borque-Fernando3,4,5, Maria Etelvina Escorihuela6
1Department of Applied Mathematics, Escuela Universitaria Politécnica de La Almunia, Universidad de Zaragoza, C/ Mayor 5, 50100, La Almunia de Doña Godina, Spain. lmeste@unizar.es.
Advanced machine learning models, including XGBoost, show superior performance in predicting clinically significant prostate cancer (CsPCa) compared to traditional logistic regression. These models can significantly reduce unnecessary biopsies, improving clinical utility and patient outcomes.
Area of Science:
- Urology
- Oncology
- Medical Imaging
- Machine Learning
Background:
- Prostate cancer (PCa) risk prediction often relies on clinical data and magnetic resonance imaging (MRI) using the Prostate Imaging-Reporting and Data System (PI-RADS).
- Current models predominantly use logistic regression, prompting exploration of advanced machine learning techniques for improved accuracy.
Purpose of the Study:
- To compare the efficacy of various machine learning models against logistic regression in predicting clinically significant prostate cancer (CsPCa).
- To evaluate the clinical utility of these models in reducing unnecessary biopsies.
Main Methods:
- A dataset of 4799 patients from Catalonia, Spain, was used with an 80-20% train-validation split.
- Predictor variables included age, PSA, prostate volume, PSAD, DRE, family history, prior negative biopsy, and PI-RADS categories.
- Models evaluated: logistic regression, ridge, LASSO, elastic net, classification trees, random forest, XGBoost, and neural networks.
Main Results:
- XGBoost demonstrated the highest specificity (0.640) at 0.9 sensitivity, closely followed by random forest and neural networks.
- XGBoost also showed the greatest potential to avoid unnecessary biopsies (41.77%), outperforming logistic regression (40.62%).
- SHAP analysis identified PI-RADS (especially 4 and 5) as the most influential factor, with DRE and family history also significant, and prior negative biopsy being protective.
Conclusions:
- Advanced machine learning models, particularly XGBoost, offer superior predictive performance and clinical utility for CsPCa detection over traditional logistic regression.
- These models can enhance decision-making, potentially reducing the number of invasive and unnecessary prostate biopsies.
- PI-RADS scores, combined with clinical factors, are crucial for accurate risk stratification, with machine learning providing a more nuanced approach.
More Related Videos
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018